HomeSMMT • NASDAQ
add
Summit Therapeutics Inc
Previous close
$15.11
Day range
$14.93 - $15.42
Year range
$13.83 - $36.91
Market cap
11.93B USD
Avg Volume
2.58M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 224.92M | 242.80% |
Net income | -219.17M | -258.11% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -224.88M | -242.85% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 713.45M | 73.02% |
Total assets | 751.18M | 72.46% |
Total liabilities | 92.32M | 97.22% |
Total equity | 658.86M | — |
Shares outstanding | 775.37M | — |
Price to book | 17.78 | — |
Return on assets | -111.03% | — |
Return on capital | -128.17% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -219.17M | -258.11% |
Cash from operations | -101.94M | -109.43% |
Cash from investing | -485.16M | -681.15% |
Cash from financing | 573.82M | 2,530.21% |
Net change in cash | -13.29M | -219.88% |
Free cash flow | -20.47M | 33.44% |
About
Founded
2003
Website
Employees
265
